window._articleFullText = window._articleFullText || {};
window._articleFullText[329] = "<div class=\"col-lg-12 col-md-12 col-sm-12 col-xs-12\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t<div  style=\"width:100%; float:left;  padding-bottom:0px;\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<div\tstyle=\"width:100%; float:left; min-height:45px; text-align:justify\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<a href=\"\" name=\"summary_en\"></a>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<!--<h2>Summary</h2>-->\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<h3>\r\n\tAbstract</h3>\r\n<p>\r\n\t<strong>Background:</strong>&nbsp;Few studies have addressed the indirect costs of chronic hepatitis B and C, and none has assessed the real costs of these conditions, including indirect costs caused by loss of work, in Turkey. Aims: This study therefore analysed the costs of treatment, follow-up, and complications of chronic hepatitis B and hepatitis C infections to the community.</p>\r\n<p>\r\n\t<strong>Study design:</strong>&nbsp;Cross-sectional study.</p>\r\n<p>\r\n\t<strong>Methods:&nbsp;</strong>This study analysed patients with chronic hepatitis B and hepatitis C treated at Pamukkale University Hospital Infectious Diseases and Clinical Microbiology Clinic, Denizli, Turkey between June 2009 and June 2010. Costs of antiviral treatment and follow-up were calculated from patients&rsquo; medical records, and indirect costs were analysed from questionnaires completed by patients.</p>\r\n<p>\r\n\t<strong>Results:&nbsp;</strong>Data were analysed for 284 patients with chronic viral hepatitis. Indirect, hospital, treatment and total expenses were significantly higher for patients with chronic hepatitis B than for inactive hepatitis B virus carriers and patients with chronic hepatitis C. Hospital and total expenses of patients with complications were significantly higher than for patients with chronic hepatitis C. Hospital and total expenses were significantly higher for patients with than for individuals without cirrhosis. Indirect, hospital, treatment and total costs of patients were significantly higher for patients receiving combination therapy than monotherapy.</p>\r\n<p>\r\n\t<strong>Conclusion:</strong>&nbsp;Reducing the costs to society of chronic hepatitis requires the development of protection and screening programs.</p>\r\n<h3>\r\n\tTurkish</h3>\r\n<p>\r\n\t<strong>Arkaplan:&nbsp;</strong>Kronik hepatit B ve C hastalıklarının dolaylı maliyetlerini inceleyen birka&ccedil; &ccedil;alışma bulunmaktadır ancak işg&uuml;c&uuml; kaybının yol a&ccedil;tığı dolaylı maliyetleri de i&ccedil;eren ger&ccedil;ek maliyetleri ortaya koyan bir &ccedil;alışma T&uuml;rkiye&rsquo;de yapılmamıştır.</p>\r\n<p>\r\n\t<strong>Ama&ccedil;:&nbsp;</strong>Bu &ccedil;alışmada kronik hepatit B ve kronik hepatit C infeksiyonlarının tedavi, takip ve komplikasyonlarının topluma maliyeti incelenmiştir.</p>\r\n<p>\r\n\t<strong>&Ccedil;alışma Tasarımı:</strong>&nbsp;Kesitsel &ccedil;alışma</p>\r\n<p>\r\n\t<strong>Y&ouml;ntemler:</strong>&nbsp;Bu &ccedil;alışma Pamukkale &Uuml;niversitesi Hastanesi İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği, Denizli, T&uuml;rkiye tarafından Haziran 2009- Haziran 2010 tarihleri arasında tedavi edilen kronik hepatit B ve hepatit C hastalarını incelemektedir. Antiviral tedavi ve takip maliyetleri hastaların tıbbi kayıtlarından hesaplanmıştır, ve dolaylı maliyetler hastalar tarafından doldurulan anketlerden hesaplanmıştır.</p>\r\n<p>\r\n\t<strong>Bulgular:</strong>&nbsp;Kronik viral hepatitli 284 hastanın verileri incelenmiştir. Kronik hepatit B hastalarının dolaylı, hastane, tedavi, ve toplam maliyetleri inaktif hepatit B taşıyıcıları ve kronik hepatit C hastalarından istatistiksel olarak anlamlı y&uuml;ksek bulunmuştur. Komplikasyonlu hastaların hastane ve toplam maliyetleri kronik hepatit C hastalarından istatistiksel olarak anlamlı y&uuml;ksek bulunmuştur. Sirozlu hastaların hastane ve toplam maliyetleri sirozu olmayan hastalardan istatistiksel olarak anlamlı y&uuml;ksek bulunmuştur. Kombinasyon tedavisi alan hastaların dolaylı, hastane, tedavi ve toplam maliyetleri monoterapi alan hastalardan istatistiksel olarak anlamlı y&uuml;ksek bulunmuştur.</p>\r\n<p>\r\n\t<strong>Sonu&ccedil;:</strong>&nbsp;Kronik hepatitlerin topluma maliyetlerini azaltmak i&ccedil;in korunma ve tarama programlarının geliştirilmesi gerekmektedir.</p>\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<!--\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<div\tstyle=\"width:20%; float:left; min-height:150px; padding:10px; padding-top:40px;\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t\t\t\t<a class=\"selected_menu\" href=\"#summary_en\">Summary</a>\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t-->\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t        \t</div>\n\t\t\t<";
